115 related articles for article (PubMed ID: 7982228)
21. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
[TBL] [Abstract][Full Text] [Related]
22. Substrate specificity of viral, bacterial and mammalian sialidases with regard to different N,O-acetylated sialic acids and GM1.
Sander-Wewer M; Schauer R; Corfield AP
Adv Exp Med Biol; 1982; 152():215-22. PubMed ID: 7136909
[No Abstract] [Full Text] [Related]
23. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.
Kim CU; Lew W; Williams MA; Liu H; Zhang L; Swaminathan S; Bischofberger N; Chen MS; Mendel DB; Tai CY; Laver WG; Stevens RC
J Am Chem Soc; 1997 Jan; 119(4):681-90. PubMed ID: 16526129
[TBL] [Abstract][Full Text] [Related]
24. Tailor made sialidase inhibitors home in on influenza virus.
Corfield T
Glycobiology; 1993 Oct; 3(5):413-5. PubMed ID: 8286849
[No Abstract] [Full Text] [Related]
25. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
[TBL] [Abstract][Full Text] [Related]
27. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
28. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
[TBL] [Abstract][Full Text] [Related]
29. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
Kaji M
Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
Palese P; Compans RW
J Gen Virol; 1976 Oct; 33(1):159-63. PubMed ID: 978183
[TBL] [Abstract][Full Text] [Related]
31. An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses.
Guo CT; Sun XL; Kanie O; Shortridge KF; Suzuki T; Miyamoto D; Hidari KI; Wong CH; Suzuki Y
Glycobiology; 2002 Mar; 12(3):183-90. PubMed ID: 11971862
[TBL] [Abstract][Full Text] [Related]
32. 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.
Hart GJ; Bethell RC
Biochem Mol Biol Int; 1995 Jul; 36(4):695-703. PubMed ID: 8528132
[TBL] [Abstract][Full Text] [Related]
33. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.
Sakamoto J; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Esumi Y; Nakamura T; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem; 2009 Aug; 17(15):5451-64. PubMed ID: 19592257
[TBL] [Abstract][Full Text] [Related]
34. Drug design. A rational attack on influenza.
Taylor G
Nature; 1993 Jun; 363(6428):401-2. PubMed ID: 8502294
[No Abstract] [Full Text] [Related]
35. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
[TBL] [Abstract][Full Text] [Related]
36. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor.
von Itzstein M; Wu WY; Jin B
Carbohydr Res; 1994 Jun; 259(2):301-5. PubMed ID: 8050102
[No Abstract] [Full Text] [Related]
37. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus.
Murakami M; Ikeda K; Achiwa K
Carbohydr Res; 1996 Jan; 280(1):101-10. PubMed ID: 8581891
[TBL] [Abstract][Full Text] [Related]
38. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Cross J; Wedekind CA
Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
[No Abstract] [Full Text] [Related]
39. Synthesis of Sulfo-Sialic Acid Analogues: Potent Neuraminidase Inhibitors in Regards to Anomeric Functionality.
Vavricka CJ; Muto C; Hasunuma T; Kimura Y; Araki M; Wu Y; Gao GF; Ohrui H; Izumi M; Kiyota H
Sci Rep; 2017 Aug; 7(1):8239. PubMed ID: 28811524
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
Hurt AC; Barr IG; Hartel G; Hampson AW
Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
